The detail
Track cycle length, flow heaviness, sleep quality, mood, hot flashes, brain fog frequency. Apps work, paper journal works. Patterns emerge over 3 months — show clinician to support diagnosis. AMH + FSH labs useful but not required for diagnosis.
Historical context
Symptom tracking used to begin only after a diagnosis. The value of tracking earlier — while patterns are still forming — became clearer as clinicians recognized that perimenopause is diagnosed from the pattern over time, not a single test.
Research landscape
The earliest reliable signal of the transition is a change in menstrual cycle length and regularity, which often appears before classic symptoms like hot flashes. Because no single blood test confirms perimenopause — hormone levels swing day to day — a documented record of cycle length, flow, and symptoms over several months is often more useful diagnostically than any lab. Starting to track when cycles first become unpredictable, or when new symptoms cluster (sleep, mood, temperature), gives a clinician the pattern they actually need.
What providers actually do
A menopause-aware clinician would rather see three to six months of a woman's own cycle-and-symptom record than order a one-time hormone panel. They encourage tracking at the first sign of cycle change, typically in the early-to-mid forties but sometimes late thirties.
Subtle red flags specific to this question
- Cycles closer than 21 days apart, or very heavy or prolonged bleeding — track it and get it assessed.
- Any bleeding after 12 months without a period — stop assuming perimenopause and seek evaluation.
- Cycle changes with severe pain, or bleeding between periods — worth a clinical review.
- Symptoms before age 40 with skipped periods — ask about testing for early/primary ovarian insufficiency.
Sources
Was this helpful?